Valuation: LifeVantage Corporation

Market Cap 7.34Cr 6.56Cr 6.06Cr 5.49Cr 10Cr 696.88Cr 10Cr 73Cr 29Cr 365.12Cr 28Cr 27Cr 1.15TCr P/E 2027 *
30.1x
P/E 2028 * 18.6x
Enterprise Value 6.07Cr 5.42Cr 5.01Cr 4.54Cr 8.49Cr 576.48Cr 8.63Cr 60Cr 24Cr 302.04Cr 23Cr 22Cr 952.24Cr EV / Sales 2027 *
0.37x
EV / Sales 2028 * 0.35x
Free-Float
86.31%
Yield 2027 *
-
Yield 2028 * -
1 day-2.73%
1 week-6.35%
Current month-11.11%
1 month-9.53%
3 months-12.09%
6 months+1.64%
Current year-9.09%
1 week 5.53
Extreme 5.5274
6.11
1 month 5.3
Extreme 5.295
6.4
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
11.71
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 63 05/08/2026
Director of Finance/CFO 53 25/10/2021
Chief Tech/Sci/R&D Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 74 01/01/2012
Director/Board Member 67 01/02/2017
Director/Board Member 68 17/02/2022
Date Insider Type Main position Quantity % Market Cap. Importance
07/10/26 Free

Chief Financial Officer

89,372 0.7099%
07/10/26 Free

Responsable ventes & marketing

82,125 0.6523%
07/10/26 Free

Chief Executive Officer

4,83,092 3.8373%
Change 5-day change 1-year change 3-year change Capi.($)
-4.44%-6.35%-34.35%-27.46% 7.34Cr
+0.50%+3.35%+55.11%+125.64% 1,13500Cr
+0.57%+4.76%+39.71%+78.43% 64TCr
+0.20%+1.43%+25.73%+97.46% 50TCr
+1.43%+4.31%+48.28%+67.12% 38TCr
-2.89%-1.27%+61.14%+34.34% 36TCr
-0.25%+2.80%+23.77%+50.05% 29TCr
+0.27%+3.71%+2.50%+23.75% 27TCr
+0.37%+3.89%+51.62%+63.68% 24TCr
+1.53%+3.89%+32.00%+102.57% 19TCr
Average -0.14%+1.21%+30.55%+61.56% 40.04TCr
Weighted average by Cap. +0.16%+1.63%+41.73%+83.76%

Financials

2027 *2028 *
Net sales 17Cr 15Cr 14Cr 12Cr 23Cr 1.57TCr 24Cr 164.25Cr 65Cr 822.92Cr 62Cr 61Cr 2.59TCr 17Cr 15Cr 14Cr 13Cr 23Cr 1.59TCr 24Cr 166.46Cr 66Cr 833.98Cr 63Cr 62Cr 2.63TCr
Net income 24.88L 22.22L 20.53L 18.6L 34.81L 24Cr 35.38L 2.47Cr 97.81L 12Cr 93.39L 91.41L 39Cr 39.96L 35.69L 32.97L 29.88L 55.9L 38Cr 56.82L 3.97Cr 1.57Cr 20Cr 1.5Cr 1.47Cr 63Cr
Net Debt -1.27Cr -1.13Cr -1.05Cr -94.82L -1.77Cr -120.4Cr -1.8Cr -13Cr -4.98Cr -63Cr -4.76Cr -4.66Cr -198.88Cr -1.49Cr -1.33Cr -1.23Cr -1.11Cr -2.08Cr -141.25Cr -2.12Cr -15Cr -5.85Cr -74Cr -5.58Cr -5.47Cr -233.31Cr
Projected Income Statement - Annual - LifeVantage Corporation
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
216
Date Price Change Volume
26/26/26 $5.600 -4.44% 7,935
23/26/23 $5.860 -2.01% 23,751
22/26/22 $5.980 +0.50% 31,374
21/26/21 $5.950 -0.34% 30,297
20/26/20 $5.970 -0.17% 22,805
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - LifeVantage Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
5.860USD
Average target price
7.500USD
Spread / Average Target
+27.99%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LifeVantage Corporation
  1. Stock Market
  2. Stocks
  3. LFVN Stock